Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Mellgard

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|November 18, 2022
Complexity, Not Severity: Reinterpreting the Sliding Scale of CapacityGeorge Mellgard, Nada Gligorov
BMC Health Services Research|November 10, 2019
Hurricanes and healthcare: a case report on the influences of Hurricane Maria and managed Medicare in treating a Puerto Rican residentGeorge Mellgard, David Abramson, Charles Okamura, et al.
Home Health Care Services Quarterly|November 23, 2021
Examining variation in state spending on medicaid long-term services and supports for older adultsGeorge Mellgard, Claire Ankuda, Omari-Khalid Rahman, et al.
American Journal of Clinical Oncology|August 1, 2024
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted TherapyGeorge Mellgard, Nathaniel Saffran, Zakaria Chakrani, et al.
American Journal of Clinical Oncology|February 12, 2024
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted TherapyZakaria Chakrani, George Mellgard, Nathaniel Saffran, et al.
Clinical Genitourinary Cancer|October 22, 2024
The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART)Zakaria Chakrani, Mann Patel, George Mellgard, et al.
Teaching and Learning in Medicine|August 12, 2023
How Are We Doing? A Scoping Review of Published Patient-Centered Outcomes Research in United States Student-Run Free ClinicsFrancesca Silvestri, George Mellgard, Jonathan Goldstein, et al.
BMC Medical Education|March 22, 2024
Evaluation of patient health outcomes of a student-run free clinic in East HarlemJoy J Jiang, Katie Link, George Mellgard, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2022
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumorsGeorge Mellgard, Vaibhav G Patel, Xiaobo Zhong, et al.
Discover Oncology|August 12, 2022
Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysisQian Qin, Tomi Jun, Bo Wang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|November 18, 2022
Complexity, Not Severity: Reinterpreting the Sliding Scale of CapacityGeorge Mellgard, Nada Gligorov
BMC Health Services Research|November 10, 2019
Hurricanes and healthcare: a case report on the influences of Hurricane Maria and managed Medicare in treating a Puerto Rican residentGeorge Mellgard, David Abramson, Charles Okamura, et al.
Home Health Care Services Quarterly|November 23, 2021
Examining variation in state spending on medicaid long-term services and supports for older adultsGeorge Mellgard, Claire Ankuda, Omari-Khalid Rahman, et al.
American Journal of Clinical Oncology|August 1, 2024
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted TherapyGeorge Mellgard, Nathaniel Saffran, Zakaria Chakrani, et al.
American Journal of Clinical Oncology|February 12, 2024
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted TherapyZakaria Chakrani, George Mellgard, Nathaniel Saffran, et al.
Clinical Genitourinary Cancer|October 22, 2024
The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART)Zakaria Chakrani, Mann Patel, George Mellgard, et al.
Teaching and Learning in Medicine|August 12, 2023
How Are We Doing? A Scoping Review of Published Patient-Centered Outcomes Research in United States Student-Run Free ClinicsFrancesca Silvestri, George Mellgard, Jonathan Goldstein, et al.
BMC Medical Education|March 22, 2024
Evaluation of patient health outcomes of a student-run free clinic in East HarlemJoy J Jiang, Katie Link, George Mellgard, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2022
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumorsGeorge Mellgard, Vaibhav G Patel, Xiaobo Zhong, et al.
Discover Oncology|August 12, 2022
Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysisQian Qin, Tomi Jun, Bo Wang, et al.
Pageof 2